Walchand People (501370)
TurnaroundScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹256.2 |
| Market Cap | ₹76.2 Cr |
| P/E Ratio | 8.19 |
| ROCE | 8.15% |
| ROE | 14.61% |
| Dividend Yield | 0.91% |
| Profit Growth | 518.18% |
| Debt/Equity | — |
| Sales Growth | 12.27% |
| 52-Week Range | ₹79.05 — ₹256.2 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹96.54 |
Strengths
- Trailing P/E of 8.19 appears inexpensive relative to reported earnings
- Sales growth of 12.27% shows modest business expansion
- Piotroski F-Score of 7/9 suggests decent financial health
- ROE of 14.61% is acceptable for a small-cap consultancy
- No reported debt on the given data, which is a positive if confirmed
Concerns
- 518.18% profit growth is likely from a low base and not sustainable
- Latest quarter profit of only ₹1 crore on ₹9 crore sales shows tiny absolute scale
- P/B of 2.65 and ROCE of 8.15% do not justify a wide-moat valuation
- Stock is at its 52-week high after nearly tripling, reducing margin of safety
AI Analysis
At ₹256, Walchand People is a ₹76 crore micro-cap in consulting services. The low P/E of 8.19 catches my eye, but Benjamin Graham warned me not to confuse a cheap multiple with a cheap business. Profit growth of 518.18% is almost meaningless; it usually reflects a low previous base, not durable earning power. Sales growth of 12.27% is respectable, but the latest quarter's ₹9 crore revenue and ₹1 crore net profit show the absolute scale is tiny. I cannot call this a wide-moat business. The balance sheet looks okay: no debt figure is reported, the Piotroski F-Score is 7/9, and ROE of 14.61% is acceptable. Yet ROCE of only 8.15% tells me the underlying capital efficiency is modest. Book value is ₹96.54, so at ₹256 I'm paying 2.65 times book for a consultancy with limited pricing power. That's not the margin of safety I seek. The stock has gone from ₹79.05 to ₹256.20 in 52 weeks. Chasing a tripled micro-cap after a 518% profit spike is dangerous. This looks more like a turnaround or cyclical recovery than a stable compounding machine. If earnings continue at this level, the P/E is cheap; if the latest quarter is the real run-rate, the market cap has less support. I need more evidence. I'd rather wait for a better price or consistent cash earnings before acting.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer